# Epidermal growth factor receptor blockade with C225 plus gemcitabine results in regression of human pancreatic carcinoma growing orthotopically in nude mice by antiangiogenic mechanisms.

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/epidermal-growth-factor-receptor-blockade-with-c225-plus-gemcitabine-results-in/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Christiane J. Bruns,Matthew T. Harbison,Darren W. Davis,Charles A. Portera,Rachel Tsan,David J. McConkey,Douglas B. Evans,James L. Abbruzzese,Daniel J. Hicklin,Robert Radinsky |
| Citations | 423 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2159506251 |
| PMID | 10815919 |
| Type | article |
| Year | 2000 |

## Paper authors

- [Christiane J. Bruns](https://scholariq.org/researchers/christiane-j-bruns/)

## Paper journal

- [PubMed](https://scholariq.org/journals/pubmed/)

## Paper primary topic

- [Cancer, Hypoxia, and Metabolism](https://scholariq.org/topics/cancer-hypoxia-and-metabolism/)

## Paper topics

- [Cancer, Hypoxia, and Metabolism](https://scholariq.org/topics/cancer-hypoxia-and-metabolism/)
- [Pancreatic and Hepatic Oncology Research](https://scholariq.org/topics/pancreatic-and-hepatic-oncology-research/)
- [Angiogenesis and VEGF in Cancer](https://scholariq.org/topics/angiogenesis-and-vegf-in-cancer/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.